why choose us

First received: October 05, 2022

Clinical Trial: Benzodiazepine Taper With Cognitive Behavioral Therapy in Patients Using Prescription Opioids

Study Status: Completed

Recruit Status: RECRUITING

Condition: Anxiety Disorders

Study Type: INTERVENTIONAL


Official Title: Augmenting the Efficacy of Benzodiazepine Taper With Telehealth-Delivered Cognitive Behavioral Therapy for Anxiety Disorders in Patients Using Prescription Opioids

Brief Summary: Taking prescription opioids for pain together with benzodiazepines for the treatment of anxiety disorders is not recommended by the U.S. Food and Drug Administration (FDA) because of the elevated risk of serious complications, including fatal overdose.However, this concurrent prescription use continues to be prevalent, likely due to the high comorbidity between pain and anxiety disorders.Efforts are urgently needed to reduce benzodiazepine use among patients taking opioids.Cognitive behavioral therapy (CBT) is a…

Read more